Chaparro María
Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, España..
Gastroenterol Hepatol. 2015 Sep;38 Suppl 1:20-31. doi: 10.1016/S0210-5705(15)30016-9.
Numerous studies were presented in Digestive Disease Week 2015 (DDW 2015) on the natural history, complications, and safety of treatments in inflammatory bowel disease (IBD), as well as novel findings on fertility, pregnancy, and breastfeeding. The present article reviews presentations on the natural history of IBD, the risk of complications and their prevention, treatment safety, aspects related to fertility, pregnancy, and breastfeeding, as well as the risk of cancer and its association with IBD and with drugs used in its treatment. In the next few years, more data will become available on treatment safety and the possible complications that can develop in IBD patients due to the disease itself and the drugs employed in its treatment, which will allow measures to be adopted to improve prognosis.
2015年消化系统疾病周（DDW 2015）上展示了众多关于炎症性肠病（IBD）的自然史、并发症及治疗安全性的研究，还有关于生育、妊娠及母乳喂养的新发现。本文回顾了有关IBD自然史、并发症风险及其预防、治疗安全性、与生育、妊娠及母乳喂养相关的方面，以及癌症风险及其与IBD和治疗所用药物的关联的报告。在未来几年，将有更多关于治疗安全性以及IBD患者因疾病本身和治疗所用药物可能出现的并发症的数据，这将有助于采取措施改善预后。
